HL - At the risk of sounding like a broken record, RVX-208 is in a double blinded Phase III trial and has been for the past 2 yrs. With a company like RVX that has limited funds(read that as never enough) this can be really boring. We are almost totally dependant on BETonMACE information to keep our interest for which there is almost none because it is a blinded trial. For RVX it's zzzzz time however the Zenith trial is not blinded so we are able to get a few nuggets of info along the way to keep our interest and hopes up. The number of nuggets from Zenith could and should be ramped up a little though. As BDAZ says in the previous post there is lots of positive info on apabetalone out, just not to much in the last couple of yrs.

tada